Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.
about
Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem CellsRecent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem CellsReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementAdvances and challenges in the differentiation of pluripotent stem cells into pancreatic β cellsRecent developments in β-cell differentiation of pluripotent stem cells induced by small and large moleculesTissue engineering approaches to cell-based type 1 diabetes therapyProhibitin 2 regulates the proliferation and lineage-specific differentiation of mouse embryonic stem cells in mitochondriaTranslational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug DiscoveryInduced pluripotent stem cell potential in medicine, specifically focused on reproductive medicineToward beta cell replacement for diabetesDirected differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitorsIslet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo.Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment.Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells.Human pancreatic beta-like cells converted from fibroblasts.Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells.Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3.Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.Efficient and simple production of insulin-producing cells from embryonal carcinoma stem cells using mouse neonate pancreas extract, as a natural inducer.Potential for pancreatic maturation of differentiating human embryonic stem cells is sensitive to the specific pathway of definitive endoderm commitment.Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 AnalogueInhibition of activin/nodal signalling is necessary for pancreatic differentiation of human pluripotent stem cells.ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β CellsDefinitive Endoderm Formation from Plucked Human Hair-Derived Induced Pluripotent Stem Cells and SK Channel Regulation.Reprogramming adult human dermal fibroblasts to islet-like cells by epigenetic modification coupled to transcription factor modulation.An inhibitor of fibroblast growth factor receptor-1 (FGFR1) promotes late-stage terminal differentiation from NGN3+ pancreatic endocrine progenitors.Stem Cells in the Treatment of Insulin-Dependent Diabetes Mellitus.Generation of functional insulin-producing cells from mouse embryonic stem cells through 804G cell-derived extracellular matrix and protein transduction of transcription factors.A synthetic peptide-acrylate surface for production of insulin-producing cells from human embryonic stem cellsActivation of Wnt/β-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes.Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culturePak3 promotes cell cycle exit and differentiation of β-cells in the embryonic pancreas and is necessary to maintain glucose homeostasis in adult mice.Potential for pharmacological manipulation of human embryonic stem cells.Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine.Potential of pluripotent stem cells for diabetes therapy.Pluripotent stem cell-derived pancreatic β-cells: potential for regenerative medicine in diabetes.From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes.Differentiation of stem cells into insulin-producing cells: current status and challenges.The use of stem cells for pancreatic regeneration in diabetes mellitus.Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes.
P2860
Q26753857-8458212D-5C84-4E33-911E-2D3EE4C5E811Q26767096-743BF47A-5E8A-436B-AF2A-7A726D617A16Q26769878-CA014E4F-B1DC-4E6B-A08A-BD19CC69EB66Q26824468-00A801ED-E134-408C-8BF6-A1F57D04EB85Q26825664-03805AB4-87EA-474F-9D73-AE6A76D2DD95Q26862805-0FEFC95F-2DF7-4B97-A544-BC5C14B50D34Q27301072-1BCA73C2-86B8-4139-AC29-C372CAB9118AQ28072402-5F45D9CD-C8AB-4494-B339-AE707005525AQ28083057-880E5E5B-7AC0-48CC-A87A-9AA285319266Q28083650-355ED61F-CDC3-4E8B-87D4-B25CCF7A9661Q28817053-62F348B1-D3FC-4E19-B6BA-308A091ED777Q30820926-43B6B27A-530D-40B4-9AC8-2CD5C03AA33CQ33746106-F91EFC7C-021B-4366-8BFC-9F5482B8AD21Q33778800-6ABD44CB-FE0A-47E7-A643-F6F5D96622F6Q34045775-3F1B19A0-C0E9-43B6-9CC6-848AF2FF0AC8Q34474853-5FD567F6-D1B6-4303-A847-18951F5EAC42Q34972402-AC08F3C3-22E2-4D94-9992-4100BCB3D5BEQ35074117-BA2ACB68-113F-4A99-B80F-04354B355719Q35116178-3BE67130-450E-45C5-B22D-2FB6E7D33680Q35151768-B37DC22F-EF71-4CFB-9066-176B9ED9A844Q35867232-6DF64AD1-21A6-4F37-B2FB-8E001CCB1897Q36353419-DB0981C1-C64E-420E-8FF1-40809EA80C3BQ36799671-53DE7F19-0A8B-45BC-83AE-623A32B2B9B1Q36845124-B938B61C-09B5-49CC-A7B3-A7B6E6C40651Q37139609-CE8A9CC8-C355-4CF3-B143-D345F41C5257Q37369046-A2598B3D-6CC9-4613-89FB-242E54C221B0Q37369660-D3DFA3AF-00F6-4A52-8A6F-654609311328Q37516473-92A2B588-B23F-4A81-99E5-AAE4CD5810D2Q37577263-2520487E-139E-44F6-80E6-DBDEB4CF41F5Q37589666-7AB3869B-10B1-43FB-B906-8A677B3B88E1Q37666725-BA1D8719-9407-4626-8E25-8869B7087A74Q37670159-B8CAB30D-ADE8-4605-A336-DCB29D9824A9Q38003694-BE059996-7318-4A26-9CA2-1E5D828B6377Q38023060-9E4E8C09-E36C-459E-AA03-3A349D0913FAQ38023290-383F4E68-F9FC-40CA-ADDD-F99AA3BCAD87Q38027921-2330C3A4-D143-4456-B985-078761FE7F0BQ38064949-D4165417-73C4-42A2-83A3-8884A67D5E87Q38071243-1C4B0E94-30C5-48BA-B1EF-6625674B89F7Q38123370-38F6E3FD-3505-45BF-B9C6-DD5BDB657CD1Q38191830-7002BE73-657E-4019-8345-D29D78BE9167
P2860
Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Small molecules induce efficie ...... nduced pluripotent stem cells.
@ast
Small molecules induce efficie ...... nduced pluripotent stem cells.
@en
Small molecules induce efficie ...... nduced pluripotent stem cells.
@nl
type
label
Small molecules induce efficie ...... nduced pluripotent stem cells.
@ast
Small molecules induce efficie ...... nduced pluripotent stem cells.
@en
Small molecules induce efficie ...... nduced pluripotent stem cells.
@nl
prefLabel
Small molecules induce efficie ...... nduced pluripotent stem cells.
@ast
Small molecules induce efficie ...... nduced pluripotent stem cells.
@en
Small molecules induce efficie ...... nduced pluripotent stem cells.
@nl
P2093
P1433
P1476
Small molecules induce efficie ...... nduced pluripotent stem cells.
@en
P2093
Masaki Hosoya
Masanobu Shoji
Noriko Tsubooka-Yamazoe
Yuya Kunisada
P304
P356
10.1016/J.SCR.2011.10.002
P577
2011-10-11T00:00:00Z